PRSS23 promotes pancreatic cancer progression through regulating Hippo-YAP activity
Biochemical and Biophysical Research Communications · 2026
DOI: 10.1016/j.bbrc.2025.153157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Zhihong Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical Univ…. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Pancreatic Neoplasms, Transcription Factors, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Wenzhou Medical University.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) remains a highly aggressive malignancy characterized by a poor prognosis, highlighting the critical need to elucidate its underlying molecular mechanisms. In this study, we demonstrate the pivotal oncogenic role of PRSS23 in PDAC pathogenesis. Clinical analyses reveal that PRSS23 is frequently overexpressed in PDAC tumor tissues, and elevated expression levels are significantly associated with reduced patient survival. Functional experiments show that PRSS23 knockdown markedly suppresses PDAC cell proliferation in vitro and inhibits tumor growth and metastasis in vivo. Transcriptomic profiling identifies the Hippo signaling pathway as a key downstream effector of PRSS23. Specifically, depletion of PRSS23 leads to inactivation of YAP, the central transcriptional co-activator of the Hippo pathway. Molecular docking simulations suggest that PRSS23 facilitates the formation of a ternary complex involving the serine/threonine phosphatase PP2A and the Hippo kinase MST1. Subsequent experimental validation confirms that PRSS23 silencing disrupts the interaction between PP2A and MST1, resulting in increased MST1 phosphorylation. This enhancement of MST1 activity promotes the phosphorylation and cytoplasmic sequestration of YAP, thereby suppressing its oncogenic transcriptional functions. Collectively, our findings establish PRSS23 as a novel prognostic biomarker and a crucial regulatory node in PDAC progression. PRSS23 drives tumorigenesis and metastasis by stabilizing the PP2A-MST1 interaction, which impairs Hippo pathway signaling and leads to aberrant YAP activation. Targeting the PRSS23/PP2A/MST1 axis may therefore represent a promising therapeutic strategy for the treatment of PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, 225300, China.
- Department of Orthopedics, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, 225300, China.
- Department of Gastroenterology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, 225300, China. Electronic addres…
- Xiangshan First People's Hospital Medical and Health Group, The Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, Zhejiang, China. Electronic address: yubeibei02020@163.com.
Förderung
- Wenzhou Medical University
Zitieren
APA
Liu, Z., Jiang, Q., Sun, Y., Song, Y., & Yu, B. (2026). PRSS23 promotes pancreatic cancer progression through regulating Hippo-YAP activity. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.153157
Vancouver
Liu Z, Jiang Q, Sun Y, Song Y, Yu B. PRSS23 promotes pancreatic cancer progression through regulating Hippo-YAP activity. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2025.153157
BibTeX
@article{Liu2026,
author = {Liu, Zhihong and Jiang, Qiuping and Sun, Yuanmeng and Song, Yiran and Yu, Beibei},
title = {PRSS23 promotes pancreatic cancer progression through regulating Hippo-YAP activity},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
doi = {10.1016/j.bbrc.2025.153157}
}
EUVIMED